Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.

Blood reviews - 1 Nov 2017

van den Brand Michiel, Scheijen Blanca, Hess Corine J, van Krieken J Han Jm, Groenen Patricia J T A

Abstract excerpt

Although patients with indolent B-cell lymphomas have a relatively good survival rate, conventional chemotherapy is not curative. Disease courses are typically characterized by multiple relapses and progressively shorter response duration with subsequent lines of therapy. There has been an explosion of innovative targeted agents in the past years. This review discusses current knowledge on the etiology of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Damage
Share to Epigenesis, Genetic
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Lymphoma, B-Cell

Share to Lymphoma, B-Cell, Marginal Zone

Share to Lymphoma, Follicular

Share to Molecular Targeted Therapy

Source

Identifiers

PMID: 28802906
DOI: 10.1016/j.blre.2017.08.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.PMID 28802906Read ↗

Malignant lymphoma: pathophysiology and current therapy.Semantic proximity Read ↗

Unraveling MCL biology to understand resistance and identify vulnerabilitiesSemantic proximity Read ↗

New Insights into Lymphoma PathogenesisSemantic proximity Read ↗

B-cell lymphoma mutations: improving diagnostics and enabling targeted therapiesSemantic proximity Read ↗

Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance.Semantic proximity Read ↗

Genetic lesions and targeted therapy in Hodgkin lymphomaSemantic proximity Read ↗

Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.Semantic proximity Read ↗

Advances in the understanding of molecular genetics and therapy of Richter transformation in chronic lymphocytic leukemia.Semantic proximity Read ↗

Recent therapeutic advances in chronic lymphocytic leukemiaSemantic proximity Read ↗

The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications.Semantic proximity Read ↗

Pathology of B-cell lymphomas: diagnosis and biomarker discovery.Semantic proximity Read ↗

Lymphoma: turning biology into cures.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.